Amarin Corp Plc (AMRN)

[ralphey]

The one point in this graph that would have to jump out to any person who has no knowledge of Vascepa but becomes familiar with indications etc is how can Lovaza with <1/10th the market share of V and gV have penetration that is 60% of V and gV ?

If lovaza has a market of 60k for 10% then V and gV should be 540K for 90%


So think about this gentleman and Lady ( Lizzy) - if Healthnet suit fails - if Marjac fails then either

1.) Vastor or

2.) WOUld it make sense to hash out a deal with gV - ask them to contribute to marketing and advertising and share this pie - even if they did a 50 50 split of expense and market share - AMRN woulD have 270K Rxs - thats a lot better than their current 75K and would represent an expansion of 260% ( head guesstimate)